Total Payments
$4,157
2024 Payments
$959.79
Companies
24
Transactions
214
Medicare Patients
2,986
Medicare Billing
$152,887
Payment Breakdown by Category
Food & Beverage$4,157 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,157 | 214 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $832.04 | 67 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $541.27 | 19 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $512.59 | 25 | $0 (2024) |
| Boston Scientific Corporation | $369.79 | 4 | $0 (2024) |
| Merck Sharp & Dohme LLC | $368.01 | 14 | $0 (2024) |
| PFIZER INC. | $331.81 | 21 | $0 (2024) |
| Abbott Laboratories | $229.17 | 9 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $197.01 | 12 | $0 (2024) |
| Amgen Inc. | $136.25 | 9 | $0 (2023) |
| ATRICURE, INC. | $88.45 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $959.79 | 47 | Novartis Pharmaceuticals Corporation ($224.44) |
| 2023 | $1,158 | 66 | Novartis Pharmaceuticals Corporation ($193.03) |
| 2022 | $1,174 | 59 | Merck Sharp & Dohme LLC ($211.88) |
| 2021 | $865.50 | 42 | Novartis Pharmaceuticals Corporation ($254.57) |
All Payment Transactions
214 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/24/2024 | Abbott Laboratories | GALLANT (Device) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/08/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $24.34 | General |
| Category: Cardiovascular | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $0.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: DIABETES | ||||||
| 09/04/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/20/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Not Applicable | ||||||
| 08/13/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.26 | General |
| Category: Cardiovascular | ||||||
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/31/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/17/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.02 | General |
| 07/15/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: WATCHMAN_IC | ||||||
| 06/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: DIABETES | ||||||
| 06/11/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/06/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/23/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Iron Deficiency Anemia | ||||||
| 05/15/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: ONCOLOGY | ||||||
| 05/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 752 | 939 | $128,172 | $41,132 |
| 2022 | 3 | 672 | 852 | $118,668 | $41,044 |
| 2021 | 4 | 749 | 1,005 | $131,850 | $40,828 |
| 2020 | 6 | 813 | 1,556 | $174,933 | $29,882 |
Total Patients
2,986
Total Services
4,352
Medicare Billing
$152,887
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 578 | 699 | $102,054 | $37,694 | 36.9% |
| 93793 | Anticoagulant management of patient taking warfarin | Facility | 2023 | 119 | 184 | $20,240 | $1,198 | 5.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Facility | 2023 | 12 | 12 | $2,736 | $1,064 | 38.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 28 | 29 | $2,842 | $1,056 | 37.1% |
| 99421 | Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | Facility | 2023 | 15 | 15 | $300.00 | $121.80 | 40.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 554 | 705 | $102,930 | $39,044 | 37.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 32 | 36 | $3,528 | $1,244 | 35.3% |
| 93793 | Anticoagulant management of patient taking warfarin | Facility | 2022 | 86 | 111 | $12,210 | $755.30 | 6.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 432 | 543 | $79,278 | $32,164 | 40.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 119 | 134 | $13,132 | $4,831 | 36.8% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Facility | 2021 | 16 | 16 | $5,120 | $1,944 | 38.0% |
| 93793 | Anti-clotting management for patient taking warfarin | Facility | 2021 | 182 | 312 | $34,320 | $1,889 | 5.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 344 | 438 | $42,924 | $13,827 | 32.2% |
| 93793 | Anti-clotting management for patient taking warfarin | Facility | 2020 | 282 | 918 | $100,980 | $6,762 | 6.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 125 | 137 | $20,002 | $5,905 | 29.5% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Facility | 2020 | 17 | 17 | $5,440 | $1,796 | 33.0% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Facility | 2020 | 17 | 17 | $3,876 | $1,209 | 31.2% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Facility | 2020 | 28 | 29 | $1,711 | $382.79 | 22.4% |
About Meredith Covington, NP
Meredith Covington, NP is a Nurse Practitioner healthcare provider based in Jackson, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821186917.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Meredith Covington, NP has received a total of $4,157 in payments from pharmaceutical and medical device companies, with $959.79 received in 2024. These payments were reported across 214 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($4,157).
As a Medicare-enrolled provider, Covington has provided services to 2,986 Medicare beneficiaries, totaling 4,352 services with total Medicare billing of $152,887. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Jackson, MS
- Active Since 10/11/2006
- Last Updated 08/21/2018
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1821186917
Products in Payments
- JARDIANCE (Drug) $512.59
- LEQVIO (Drug) $506.11
- ELIQUIS (Drug) $402.41
- FARXIGA (Drug) $365.10
- VERQUVO (Drug) $338.85
- ENTRESTO (Drug) $325.93
- WATCHMAN Access System (Device) $254.80
- Repatha (Biological) $136.25
- BRILINTA (Drug) $132.07
- CardioMEMS HF System (Device) $120.90
- WATCHMAN (Device) $114.99
- GALLANT (Device) $89.84
- CAMZYOS (Drug) $89.75
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $88.45
- XARELTO (Drug) $80.07
- ONPATTRO (Drug) $65.83
- Arcalyst (Drug) $65.33
- Inpefa (Drug) $50.81
- INJECTAFER (Drug) $42.88
- VYNDAQEL (Drug) $36.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Jackson
Mrs. Joanna Warren, Rn, Msn, Cfnp, RN, MSN, CFNP
Nurse Practitioner — Payments: $48,777
Nurse Practitioner $48,777
Kerry Carr, Fnp, FNP
Nurse Practitioner — Payments: $18,236
Nurse Practitioner $18,236
Mr. Brandon Chambers, Fnp-C, FNP-C
Nurse Practitioner — Payments: $11,473
Nurse Practitioner $11,473
Mrs. Jennifer Holly, Np, NP
Nurse Practitioner — Payments: $10,695
Nurse Practitioner $10,695
Hannah Keel, Fnp, FNP
Nurse Practitioner — Payments: $8,013
Nurse Practitioner $8,013
Lynne Currie, Np, NP
Nurse Practitioner — Payments: $7,823
Nurse Practitioner $7,823